Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n)

ABSTRACT

The present study was designed to evaluate the antidepressant potential of 5-HT3 receptor antagonist N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n). The compound '6n' with optimum log P and pA, value identified from a series of compounds synthesized in our laboratory was subjected to forced Swim Test (FST) (1, 2, and 4 mg/kg, i.p) and Tail Suspension Test (TST) (1, 2, and 4 mg/kg, i.p.). The compound '6n' significantly reduced the duration of immobility in mice without affecting the baseline locomotion. Moreover, '6n' (2 mg/kg, i.p.) potentiated the 5-hydroxytryptophan (5-HTP)-induced head twitch responses in mice and '6n' at tested dose (1 and 2 mg/kg, i.p.) reversed the reserpine-induced hypothermia in rats. In interaction studies of '6n' with various standard drugs/ligands using FST, '6n' (1 mg/kg, i.p.) potentiated the antidepressant effect of venlafaxine (4 and 8 mg/kg, i.p.) and fluoxetine (10 and 20 mg/kg, i.p.). Additionally, '6n' (1 and 2 mg/kg, i.p.) influenced the effect of harmane (5 mg/kg, i.p.) as well as reversed the effect of parthenolide (1 mg/kg, i.p.) by reducing the duration of immobility in FST. Furthermore, '6n' (1 mg/kg, i.p.) potentiated the effect of bupropion (10 and 20 mg/kg, i.p.) in TST. Chronic '6n' (1 and 2 mg/kg, i.p.) treatment attenuated the behavioral abnormalities in olfactory bulbectomized rats. In conclusion, these various findings reiterated the antidepressant-like effects of '6n' in behavioral models of depression.

KEYWORDS

• 5-HT
• receptor antagonists
• forced swim test
• head twitch
• reserpine
• tail suspension test

Showing references and in-text citations exactly as published.

• DOI10.4103/0975-1483.104367Copy

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 4, ISSUE 4Efficacy of Extrinsic Stain Removal by Novel Dentifrice Containing Papain and Bromelain ExtractsChakravarthy PK, Acharya S · pp. 245–249PharmacologySame type: Article
• Article · VOLUME 4, ISSUE 4Association between Medication Adherence Outcomes and Adverse Drug Reactions to Highly Active Antiretroviral Therapy in Indian Human Immunodeficiency Virus-Positive PatientsRajesh R, Sudha V, Varma DM, Sonika S · pp. 250–260PharmacologySame type: Article
• Article · VOLUME 4, ISSUE 4Formulation and in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drugGharti KP, Thapa P, Budhathoki U, Bhargava A · pp. 201–208Same type: Article
• Article · VOLUME 4, ISSUE 4Flurbiprofen-Loaded Stealth Liposomes: Studies on the Development, Characterization, Pharmacokinetics, and BiodistributionBegum XY, Abbulu K, Sudhakar M · pp. 209–219Same type: Article